Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DRI Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence in the United States; European Union; Japan, and Rest of the world.


TSX:DHT.UN - Post by User

Post by Possibleidiot01on Feb 02, 2024 3:16pm
149 Views
Post# 35860199

roundup

roundup
  • DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at Stifel Nicolaus from C$20.00 to C$21.00. They now have a "buy" rating on the stock. This represents a 47.6% upside from the current price of C$14.23.
  •  
  • DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at Scotiabank from C$22.00 to C$24.00. They now have an "outperform" rating on the stock. This represents a 68.7% upside from the current price of C$14.23.
  •  
  • DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at CIBC from C$18.00 to C$19.00. They now have an "outperform" rating on the stock. This represents a 33.5% upside from the current price of C$14.23.
  •  
  • DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at Raymond James from C$21.00 to C$22.00. They now have an "outperform" rating on the stock. This represents a 54.6% upside from the current price of C$14.23.
  •  
  • DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at National Bankshares, Inc. from C$18.50 to C$22.00. They now have an "outperform" rating on the stock. This represents a 54.6% upside from the current price of C$14.23.


<< Previous
Bullboard Posts
Next >>